Yanuki
Finance / Healthcare
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will participate in Citi’s 2025 Global Healthcare Conference on December 3, 2025. CFO Charlie Wagner and CSO David Altshuler will engage in a fireside chat at 9:00 a.m. ET. A live webcast w...
Money / Markets
Vertex Pharmaceuticals (NASDAQ:VRTX) is preparing to announce its latest earnings. Investors are keen to understand how the stock will react, considering its historical performance and recent financial results.
Finance / Earnings
Vertex Pharmaceuticals (VRTX) reported a 12% increase in total revenue for the second quarter of 2025, reaching $2.96 billion. This growth was fueled by strong performance in cystic fibrosis (CF) therapies and the successful launches of new...
